Table 2.
Series | Year | Patients (n) |
Female (n) |
Cure (%) |
Improvement (%) |
Failure (%) |
Length of follow-up (months) |
---|---|---|---|---|---|---|---|
Buda et al | 1976 | 42 | NA | 76 | 14 | 10 | 72 |
Stoney et al | 1978 | 24 | 22 | 38 | 52 | 10 | 36 |
Bergentz et al | 1979 | 40 | NA | 66 | 24 | 10 | 36 |
Lawrie et al | 1980 | 113 | NA | 43 | 24 | 33 | 49 |
Jakubowski et al | 1981 | 75 | 64 | 50 | 22 | 36 | 72 |
Stoney et al | 1981 | 78 | 64 | 66 | 32 | 1 | 67 |
Stanley et al | 1982 | 144 | 133 | 55 | 39 | 6 | 60 |
Bardram et al | 1985 | 17 | 17 | 65 | 18 | 18 | 120 |
Lüscher et al | 1986 | 33 | 26 | 52 | 45 | 3 | 30 |
Morin et al | 1986 | 22 | 16 | 48 | 48 | 5 | 60 |
Novick et al | 1987 | 120 | 91 | 63 | 30 | 7 | 36 |
Van Bockel et al | 1987 | 53 | 40 | 53 | 34 | 13 | 77 |
Hägg et al | 1987 | 22 | 22 | 55 | 36 | 9 | 36 |
Hansen et al | 1992 | 43 | 31 | 43 | 49 | 8 | 24 |
Murray et al | 1994 | 68 | 61 | 74 | 23 | 2 | 90 |
Andersen et al | 1995 | 40 | 35 | 33 | 57 | 10 | 40 |
Wong et al | 1999 | 19 | 18 | 31 | 58 | 11 | 56 |
Reiher et al | 2000 | 101 | 80 | 36 | 31 | 33 | 66 |
Chiche et al | 2003 | 30 | 19 | 96 | 0 | 4 | 62 |
Marekovic et al | 2004 | 72 | 56 | 80 | 10 | 10 | 132 |
Carmo et al | 2005 | 26 | 22 | 27 | 60 | 13 | 29 |
Lacombe and Ricco | 2006 | 25 | 15 | 84 | 12 | 4 | 69 |
Crutchley et al | 2007 | 37 | 30 | 15 | 65 | 20 | 34 |
Robinson et al | 2011 | 24 | 17 | NA | 94 | 6 | 99 |
Balzer et al | 2012 | 17 | 16 | NA | 73 | 27 | 50 |
Total | 1,285 | 895 |
Note: This table was adapted from Rutherford’s Vascular Surgery, 7th ed, Cronenwett JL, Johnston W, Optimal management of renal artery fibromuscular dysplasia, 2226–2242, Copyright Saunders, an imprint of Elsevier Inc. (2010).14
Abbreviation: NA, data not available.